Shares of The Procter & Gamble Company (NYSE:PG - Get Free Report) were up 0.3% during trading on Tuesday . The company traded as high as $168.70 and last traded at $168.63. Approximately 823,754 shares traded hands during trading, a decline of 88% from the average daily volume of 6,731,215 shares. The stock had previously closed at $168.11.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on PG shares. Hsbc Global Res upgraded Procter & Gamble to a "strong-buy" rating in a report on Friday, October 4th. Barclays cut shares of Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 price target for the company. in a research report on Monday, September 30th. Royal Bank of Canada reiterated a "sector perform" rating and set a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. JPMorgan Chase & Co. increased their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an "overweight" rating in a report on Thursday, September 19th. Finally, Piper Sandler assumed coverage on Procter & Gamble in a report on Tuesday, September 24th. They set a "neutral" rating and a $174.00 target price on the stock. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $180.45.
Check Out Our Latest Stock Report on PG
Procter & Gamble Stock Up 0.5 %
The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The firm's fifty day moving average price is $170.71 and its two-hundred day moving average price is $169.81. The stock has a market cap of $397.86 billion, a price-to-earnings ratio of 29.13, a price-to-earnings-growth ratio of 3.70 and a beta of 0.44.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company's quarterly revenue was down .6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.83 earnings per share. Sell-side analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.38%. Procter & Gamble's dividend payout ratio (DPR) is presently 69.31%.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CEO Gary A. Coombe sold 47,847 shares of the firm's stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Susan Street Whaley sold 634 shares of the company's stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the sale, the insider now owns 19,341 shares of the company's stock, valued at approximately $3,319,882.65. The trade was a 3.17 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 83,080 shares of company stock valued at $14,629,038. Corporate insiders own 0.18% of the company's stock.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in PG. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble in the 2nd quarter worth approximately $28,000. Fairway Wealth LLC bought a new stake in Procter & Gamble during the second quarter worth $29,000. RPg Family Wealth Advisory LLC purchased a new position in Procter & Gamble in the third quarter worth $33,000. Quest Partners LLC bought a new position in Procter & Gamble in the 2nd quarter valued at $36,000. Finally, Fairfield Financial Advisors LTD purchased a new stake in shares of Procter & Gamble during the 2nd quarter valued at $44,000. 65.77% of the stock is owned by institutional investors.
About Procter & Gamble
(
Get Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Stories
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.